WO2005065640A8 - Nouvelles compositions pour formes posologiques orales, et procede de preparation de telles compositions - Google Patents
Nouvelles compositions pour formes posologiques orales, et procede de preparation de telles compositionsInfo
- Publication number
- WO2005065640A8 WO2005065640A8 PCT/IN2005/000003 IN2005000003W WO2005065640A8 WO 2005065640 A8 WO2005065640 A8 WO 2005065640A8 IN 2005000003 W IN2005000003 W IN 2005000003W WO 2005065640 A8 WO2005065640 A8 WO 2005065640A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compositions
- preparing
- dosage forms
- drug release
- buccal dosage
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
YUP-2005/0835A RS20050835A (en) | 2004-01-06 | 2005-01-05 | Compositions of buccal dosage forms for extended drug release and the process of preparing such compositions |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN26DE2004 | 2004-01-06 | ||
IN24/DEL/2004 | 2004-01-06 | ||
IN24DE2004 | 2004-01-06 | ||
IN26/DEL/2004 | 2004-01-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005065640A1 WO2005065640A1 (fr) | 2005-07-21 |
WO2005065640A8 true WO2005065640A8 (fr) | 2005-12-08 |
Family
ID=34751866
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2005/000003 WO2005065640A1 (fr) | 2004-01-06 | 2005-01-05 | Nouvelles compositions pour formes posologiques orales, et procede de preparation de telles compositions |
Country Status (2)
Country | Link |
---|---|
RS (1) | RS20050835A (fr) |
WO (1) | WO2005065640A1 (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007096906A2 (fr) * | 2006-02-27 | 2007-08-30 | Panacea Biotec Ltd. | Nouvelles compositions bucco-adhésives et procédé d'élaboration desdites compositions |
CN100450548C (zh) * | 2006-12-22 | 2009-01-14 | 江苏奥赛康药业有限公司 | 一种波拉克林树脂组合物的口腔贴片及其制备方法 |
WO2008155620A1 (fr) * | 2007-06-20 | 2008-12-24 | Develco Pharma Schweiz Ag | Forme posologique contenant une matrice dispersible de granulés à libération entretenue |
US8133506B2 (en) | 2008-03-12 | 2012-03-13 | Aptalis Pharmatech, Inc. | Drug delivery systems comprising weakly basic drugs and organic acids |
US20140371210A1 (en) * | 2011-10-13 | 2014-12-18 | Jaleva Pharmaceuticals, Llc | Methods and compositions for rapid transbuccal delivery of active agents |
EP2906210A4 (fr) * | 2012-10-12 | 2016-06-08 | Jaleva Pharmaceuticals Llc | Procédé de préparation de teintures de résine |
US10220194B2 (en) | 2012-11-28 | 2019-03-05 | Advanced Resin Therapeutics, Inc. | Dual chamber applicator |
CN105232502A (zh) * | 2015-02-10 | 2016-01-13 | 万全万特制药江苏有限公司 | 含波拉克林钾和盐酸氟西汀复合物的口崩片及其制备方法 |
WO2017013678A1 (fr) * | 2015-07-23 | 2017-01-26 | Athena Drug Delivery Solutions Pvt Ltd. | Composition de zolpidem et son procédé de préparation |
CN114344241B (zh) * | 2021-12-15 | 2024-01-30 | 悦康药业集团安徽天然制药有限公司 | 一种聚丙烯酸树脂改性吸附药物载体及其制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1238072B (it) * | 1990-01-19 | 1993-07-03 | Sclavo Spa | Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina |
JP2000505090A (ja) * | 1996-07-11 | 2000-04-25 | ファーマーク、ニーダーランド、ベスローテン、フェンノートシャップ | インドール選択的セロトニンアゴニストを含む包接錯体 |
DE19932603A1 (de) * | 1999-07-13 | 2001-01-25 | Gruenenthal Gmbh | Wirkstoffhaltiger Mehrschichtfilm aus in situ vernetzten hydrophilen Polymeren |
CA2438272A1 (fr) * | 2001-03-02 | 2002-10-10 | John Macor | Composes utiles comme modulateurs des recepteurs de la melanocortine et compositions pharmaceutiques renfermant ceux-ci |
US7276246B2 (en) * | 2003-05-09 | 2007-10-02 | Cephalon, Inc. | Dissolvable backing layer for use with a transmucosal delivery device |
-
2005
- 2005-01-05 WO PCT/IN2005/000003 patent/WO2005065640A1/fr active Application Filing
- 2005-01-05 RS YUP-2005/0835A patent/RS20050835A/sr unknown
Also Published As
Publication number | Publication date |
---|---|
WO2005065640A1 (fr) | 2005-07-21 |
RS20050835A (en) | 2007-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1806149A4 (fr) | Préparation médicinale solide améliorée en termes de solubilité et de stabilité et procédé servant à produire celle-ci | |
AP2006003596A0 (en) | A pharmaceutical composition for the treatment of cardiovascular and cerebrovascular diseases. | |
HK1111902A1 (en) | Controlled release complex formulation for oral administration of medicine for diabetes and method for the preparation thereof | |
IL220480A0 (en) | 1-benzyl-pyrimidine-2,4-dione derivatives as dipeptidyl peptidase inhibitors , preparation method thereof, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments | |
ZA200608029B (en) | Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs | |
WO2008002245A3 (fr) | Nouveaux composés 385 | |
IL163831A (en) | Derivatives of aminoindazoles, pharmaceutical compositions comprising them, process for their preparation and use thereof | |
EP1757273A4 (fr) | Preparation pour administration orale | |
ZA200704246B (en) | Solid medicinal preparation improved in solubility and stability and process for producing the same | |
EP1731139A4 (fr) | Preparation pharmaceutique de type s/o et procede de production associe | |
IL204947A0 (en) | Phenylacetamido-thiazole derivatives, process for their preparation and their use in the manufacture of medicaments, pharmaceutical compositions and kits comprising them | |
WO2007144169A3 (fr) | Dérivés d'entacapone | |
IL162765A (en) | Diazabicycle derivatives, processes for their preparation, pharmaceutical compositions comprising them and their medical use | |
EP1811967A4 (fr) | Methodes et formulations permettant de preparer des compositions pharmaceutiques contenant du bupropion | |
AU2003221699A1 (en) | Pharmaceutical preparation for taste masking | |
IL181022A0 (en) | Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical compositions comprising the same | |
HUP0401522A2 (en) | New 4-benzylidene-piperidine derivatives, pharmaceutical compositions containing the same and process for their preparation | |
WO2005065640A8 (fr) | Nouvelles compositions pour formes posologiques orales, et procede de preparation de telles compositions | |
HUP0401523A2 (en) | Indole-2-carboxamide derivatives, pharmaceutical compositions containing them and process for producing them | |
AU2003232941A1 (en) | N-mercaptoacyl phenyalanine derivatives, process for their preparation, and pharmaceutical compositions containing them | |
WO2005120518A3 (fr) | Utilisation d'analogues d'atp pour le traitement des maladies cardio-vasculaires | |
AU2003208673A1 (en) | Pacifier for administering flavour substances | |
WO2004009085A3 (fr) | Comprimes de sumatriptan a gout masque et procedes de fabrication | |
HK1100424A1 (en) | Oral preparations and process for production thereof | |
WO2007144699A3 (fr) | Procédé pour la préparation d'alfuzosine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: P-2005/0835 Country of ref document: YU |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WR | Later publication of a revised version of an international search report | ||
CFP | Corrected version of a pamphlet front page |
Free format text: UNDER (54) PUBLISHED TITLE REPLACED BY CORRECT TITLE |
|
NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: DE |
|
122 | Ep: pct application non-entry in european phase |